StemCell Therapy

Catalysing ancient wisdom and modern science for the health and well-being of people and planet

Traditional medicine has been central to peoples health and well-being across cultures and countries for centuries. It has contributed to foundational medical texts and modern scientific breakthroughs. Landmark drugs like aspirin and artemisinin, as well as practices like yoga and meditation, originate from traditional medicine. Traditional medicine is at the frontiers of modern science and health care with advances in genomics and artificial intelligence, and personalized, holistic approaches. Increasing global attention is fueling related industries like bioeconomy and wellness valued at trillions of dollars.

Around 90% of WHO Member States have reported on the use of traditional medicine and requested robust evidence and data to guide policies, practice and regulations to ensure its safe and effective use, while promoting equity and sustainability.

To address this global demand, WHO established the Global Traditional Medicine Centre (GTMC) in 2022 with foundational support from the Government of India. The GTMC is a WHO Headquarters department, in the Division of Universal Health Coverage and Life Course, that is outposted to Jamnagar, Gujarat, India. The Centre focuses on advancing research, facilitating knowledge exchange, conserving biodiversity, and fostering partnerships to catalyze ancient wisdom and modern science for the health and well-being of people and planet.

The regional inputs are crucial for the draft WHO Global Strategy for Traditional Medicine 2025-2034 which is being formulated and the draft version...

The Fourth Forum was convened in Siem Reap on 2829 November 2022 in a hybrid format and brought together 216 participants from across the Western...

Siddha medicine is a popular health resource used across the world. Standard terminology relating to Siddha medicine is, therefore, an essential tool for...

Ayurveda is one of the popularly applied health resources across the globe. Standard terminology of Ayurveda is an essential tool for working on other...

The first WHO Traditional Medicine Global Summit Towards health and well-being for all was held in Gandhinagar, Gujarat, India, on 17-18...

Traditional and complementary medicine (T&CM) is an important and often underestimated health care resource. It has strong potential for preventing...

Following a high-level policy dialogue between the Director-General of WHO and Chinas National Administration of Traditional Chinese Medicine (NATCM)...

Get an overview of the WHOs Global Centre for Traditional Medicine (GCTM) initiative. Further explore the GCTM technical work streams and milestones,...

Multimedia

Traditional, complementary and integrative medicine in the WHO HQ and regions

African traditional medicine

Traditional Arab and Islamic medicine, including Unani

Ayurveda, yoga, unani, nuad Thai

Traditional Chinese medicine, acupuncture, tuina

Integrated Health Service Department

Related health topics

Read this article:
WHO Global Traditional Medicine Centre

Traditional medicine

Traditional medicine has a long history. It is the sum total of the knowledge, skill, and practices based on the theories, beliefs, and experiences indigenous to different cultures, whether explicable or not, used in the maintenance of health as well as in the prevention, diagnosis, improvement or treatment of physical and mental illness.

Complementary medicine

The terms complementary medicine or alternative medicine refer to a broad set of health care practices that are not part of that countrys own tradition or conventional medicine and are not fully integrated into the dominant health-care system. They are used interchangeably with traditional medicine in some countries.

Herbal medicines

Herbal medicines include herbs, herbal materials, herbal preparations and finished herbal products, that contain as active ingredients parts of plants, or other plant materials, or combinations.

Original post:
Traditional, Complementary and Integrative Medicine

Communities and families in the Western Pacific Region use traditional and complementary medicine extensively for a variety of health problems, from minor ailments to life-threatening diseases. It is sometimes the only available and affordable option, especially in remote or under-served areas. Thus, it plays an important role in primary health care.

Traditional and complementary medicine is a health practice with strong historical and cultural roots. Since it has often evolved as part of a particular cultural heritage, the forms of traditional medicine vary widely across the Region. Some forms are highly developed and well documented. They are based on systematized knowledge, comprehensive methodology and historical experience. A number of less complex traditional medicine practices also exist within small and sometimes isolated ethnic groups, based largely on local experience. The knowledge may not be documented, often being transmitted orally from generation to generation.

Read the rest here:
Traditional medicine in the Western Pacific - World Health Organization ...

Worldwide, traditional, complementary, and integrative medicine (TCI) is central to health and well-being for millions of people. At the Permanent Mission of India in Geneva today the World Health Organization (WHO) signed a new multi million five-year agreement with the Ministry of AYUSH, Government of India to boost the development of new TCI technical documents by WHO.

This collaboration will play an important role not only in the globalization of evidence-informed traditional, complementary, and integrative medicine but also in mainstreaming proven TCI practices in national health systems towards achieving universal health coverage and well-being, said Dr. Bruce Aylward, Assistant Director-General of the Universal Health Coverage and Life Course Division of WHO.

His Excellency Shri Indra Mani Pandey, Permanent Representative of India to the United Nations and other International Organizations in Geneva, in signing the agreement stated Todays signing of this agreement will not only support the development of the TCI Global Strategy - but it will also support the integration of evidence-based Traditional and Complementary Medicine in national health systems, bio-diversity conservation and the sustainability of medicinal plants. India is committed to working with WHO to strengthen Traditional Medicine Systems globally and especially in supporting fellow developing countries in promoting their own traditional medicine systems.

The Government of India has been a long-time supporter of the WHO Traditional, Complementary, and Integrative medicine unit. The unit develops key benchmark documents, standardized terminologies, and other evidence-informed technical products to enhance the acceptability and credibility of the traditional medicine systems. The new agreement, the third in a series of such agreements, exemplifies Indias commitment to both technical and financial collaboration with WHO on this important area of work.

In August 2023 in Gujarat, India, where the new WHO Global Centre for Traditional Medicine was established, the first traditional medicine global summit launched the Gujarat Declaration. The declaration paves the way for collaborative efforts in making traditional medicine an important component of national health systems.

Through this new agreement, the Government of India will continue to support WHO to develop benchmarks for training and practice in Siddha, training modules on the quality and safety of herbal medicines, the international herbal pharmacopoeia among other activities over the next five years for the advancement of traditional medicine.

Read more here:
New WHO and Ministry of AYUSH, Republic of India agreement signed to ...

Civil society organizations highlight the essential role of traditional, complementary and integrative health in addressing global health challenges, and opportunities for its integration into health systems

WHO Director-General, Dr Tedros Adhanom Ghebreyesus and a group of WHO senior officials met with representatives of civil society on 3 July, to discuss their priorities on traditional, complementary and integrative medicine, in the lead up to the WHO Traditional Medicine Global Summit on 17 and 18 August 2023 in Gandhinagar, Gujarat, India.

The virtual dialogue was coordinated by the Peoples Declaration for Traditional, Complementary and Integrative Healthcare, a worldwide civil society coalition of users and practitioners of traditional, complementary and integrative healthcare. Representatives of more than 300 civil society organisations (CSOs) and over 600 people were in attendance, bringing the full force of the knowledge and expertise on traditional, complementary and integrative health (TCIH) to the forefront.

In his opening remarks, Dr Tedros said: Traditional, complementary, and integrative health is rooted in the knowledge and resources of communities. For millions of people around the world, it is their first stop for health and well-being, and an integral part of their health system. It is for precisely these reasons that dialogues with civil society organizations are so important to WHO, as we shape our guidance and policy recommendations for countries.

WHO has started the development of the new traditional medicine strategy 2025-2034 as requested by its Member States at the World Health Assembly in May 2023, during which they have also extended WHO traditional medicine strategy: 2014-2023 for another two years, until 2025. Suggestions and proposals from the civil society will contribute to this important task, and will also inform the work of the WHO Global Centre for Traditional Medicine to harness the potential of traditional medicine from across the world to improve the health of people and the planet. Furthermore, the dialogue will contribute to WHO work on traditional, complementary and integrative medicine (TCIM), which seeks to respond to requests from countries for evidence and data to inform policies and practice, global standards and regulation to ensure safety, quality, equitable access and use, and support for scientific, innovation and technological advances in traditional medicine practices.

In the dialogue, CSOs stressed that traditional and complementary systems offer a holistic understanding of the human being and its interconnectedness with the world, and as such, can contribute to a positive vision of health that integrates the physical, the mental, the spiritual, and a social well-being. Recalling the Declaration of Astana and its specific references to the role of traditional knowledge in strengthening primary health care and improving health outcomes, CSOs stressed that the key questions is how to integrate and harness TCIH in a way that makes health services more health promoting and more in balance with the health of our planet.

Patients are demanding real choice in health care with the diversity of approaches that reflect and respect the individual, their culture and their beliefs and that are fully integrated into health care. When the health care services match the desire and choice of patients, this results in better health outcomes and greater satisfaction by patients. CSOs pointed to insufficient integration of TCIH into policy, especially in providing universal health coverage, citing the example of millions of TCIH practitioners and providers in the world, who often make health care accessible and affordable to many people.

Speaking about research, CSOs stressed that although there is an established evidence base for TCIH, integration into health systems has not yet happened and lack of evidence is often cited as a barrier. CSOs supported a dramatic increase in research activity, commensurate with TCIH use, and called for a more complex research agenda, to include products, practices and practitioners.

CSO representatives also spoke about the importance of training and continuous professional development of TCIH practitioners, and about specific registration, pathway and monitoring of TCIH products to ensure safely effectiveness and accessibility for all.

TCIH - which includes the diversity and complexity of Indigenous knowledge and traditional, complementary and integrative medicine systems - shows how the philosophical differences in practicing of medicine need to be respected, a speaker said. Indigenous knowledge must be protected, and Indigenous voices included, leading the process and upholding Indigenous world view where the collective is considered more important than the individual.

WHO respects the vast Indigenous knowledge systems and traditional complementary, integrative health approaches that have evolved over centuries in a diversity of contexts, in countries across the world, said Dr Shyama Kuruvilla, WHO lead for the Global Traditional Medicine Centre and Summit. WHOs role as the lead United Nations technical agency on health is to strengthen the evidence base and the data to support safe, scalable, effective, equitable, and optimal use, and to support equitable sharing of benefits.

Dr Kim Sungchol, head of WHO Traditional, Complementary and Integrative Medicine (TCIM) Unit said: Given the importance of the person-centred and integrative healthcare, WHO has already started working on developing policy guideline on integration of TCI into healthcare delivery system. The objective is to help and support Member States in formulating policies and programmes to maximize the potential contribution of TCI to achieving the highest possible level of health and wellbeing of the people, in line with their own contexts and realities.

Some of the civil societys asks - accelerating research agenda on TCIM, integration into health systems or regulation of TCIM products - are already embedded in WHO work, both in the TCIM strategy and in our operational and work planning as we go forward, noted Dr Bruce Aylward, Assistant Director-General, Universal Health Coverage and Life Course. After COVID-19, people value their health in a different way, and this represents an opportunity.

This virtual dialogue was part of a series of CSO Dialogues with the WHO Director-General to better understand civil society priorities and strengthen the important relationship between WHO and civil society organizations. Since October 2020, when the Dialogues first started, 16 have been organized on topics ranging from gender, youth, healthy ageing, social participation and accountability, climate and health, and more.

The Dialogues are CSO led civil society sets the agenda and presents their asks to WHO. Their objectives are to find concrete proposals and solutions to support the achievement of WHOs Triple Billion targets and to accelerate the attainment of Sustainable Development Goals.

Go here to see the original:
WHO Director-General discusses priorities on traditional, complementary ...

The first-ever World Health Organization (WHO) Traditional Medicine Global Summit 2023 closed on 18 August, with a strong commitment from the diverse and unique groups of partners and stakeholders to harness the potential of the evidence-based traditional, complementary and integrative medicine (TCIM) to improve progress towards universal health coverage and Sustainable Development Goals by 2030 for the health and well-being of people and the planet.

Health ministers from G20 and other countries, scientists, practitioners of traditional medicine, health workers and members of civil society from 88 countries participated in the Summit that took place in Gandhinagar, Gujarat, India on 17 and 18 August 2023.

The Summit provided a platform for all stakeholders to share their unique experiences, best practices and ideas for collaboration. It included a diverse group of Indigenous Peoples from different regions of the world (e.g. Australia, Bolivia, Brazil, Canada, Guatemala and New Zealand, among others) for whom many TCIM approaches play a fundamental role in not just health care, but also culture and livelihoods.

Preliminary findings from the WHO Global Survey on Traditional Medicine 2023 shared at the Summit indicate that around 100 countries have TCIM related national policies and strategies. In many WHO Member States, TCIM treatments are part of the essential medicine lists, essential health service packages, and are covered by national health insurance schemes. A large majority of people seek traditional, complementary and integrative medicine interventions for treatment, prevention and management of noncommunicable diseases, palliative care and rehabilitation.

Dr Bruce Aylward, Assistant Director-General, Universal Health Coverage, Life Course at WHO, highlighted the need for a stronger evidence basea WHO priorityto enable countries to develop appropriate regulations and policies around traditional, complementary, and integrative medicine.

The Summit also highlighted the important role that artificial intelligence can play to mine complex data available on traditional medicine and identify practices that show promise for further scientific evaluation. Eventually, and with ethical and equity safeguards, this evidence can translate into policies that accelerate the safe and effective use of traditional medicine into health systems.

In closing the Summit, Dr Hans Kluge, WHO Regional Director for Europe said, Together, we have gently shaken up the status quo that has, for far too long, separated different approaches to medicine and health. By taking aim at silos, we are saying we will collaborate all the more to find optimal ways to bring traditional, complementary and integrative medicine well under the umbrella of primary health care and universal health coverage. He further added, We have reiterated how crucial it is to get better evidence on the effectiveness, safety and quality of traditional and complementary medicine. That means innovative methodologies for assessing and evaluating outcomes.

Dr Shyama Kuruvilla, Senior Strategic Adviser and lead for the WHO Traditional Medicine Global Centre, who also led the organization of the Summit said, We learnt much about the existing policies, tools and practices. But it is clear we have a long journey ahead in using science to further understand, develop and deliver the full potential of TCIM approaches to improve peoples health and well-being in harmony with the planet that sustains us.

The Summits summary document included conclusions and commitments from participants on wide-ranging issues, from global policy, leadership, innovation, health workforce, data, evidence, monitoring, regulation, legal frameworks and protecting biodiversity and sustainable development.

Continued here:
Global partners commit to advance evidence-based traditional ...

The WHO Evidence to Policy and Impact Unit (Research for Health Department) and the Evidence Unit of the WHO Global Centre for Traditional Medicine are are hosting a collaborative side event at the 2024 Prince Mahidol Award Conference (PMAC) exploring the current state of Evidence-informed policy-making (EIDM) institutionalization globally and the implications of its intersections with Traditional, Complementary, and Integrative Medicine (TCIM) in fostering inclusivity, health equity, epistemic justice, and decolonial global health governance. The side event will explore potential mechanisms (infrastructure, conditions, frameworks) for enhancing the use of evidence in global policy development toward realizing TCIMs contribution to health and wellbeing.

The use of evidence in policy and decision-making has exponentially grown, and it is now considered standard practice within health systems. However, the gap between research and practice persists. The WHO has advanced initiatives that promote the institutionalization of Evidence-informed decision/policy-making (EIDM), such theEvidence-Informed Policy Network (EVIPNet), and tools, such as theWHO checklist for supporting the routine use of evidence during the policy-making process. The checklist, currently pilot-tested to assess its validity and feasibility, highlights six domains (governance; standards and routinized processes; leadership and commitment; resources and capacity-building/strengthening; partnership, collective action, and support; and culture), and five processes of EIDM institutionalization.

TheGujarat Declarationof thefirst WHO Global Summit on Traditional Medicine(17-18 August 2023, Gandhinagar, India) articulated an action agenda including a focus on research and evidence. It proposed making appropriate use of existing and new research, evidence syntheses and knowledge translation principles and WHO initiatives. It also recommended capacity strengthening to produce, translate and use TCIM research and Indigenous knowledges and supporting the evidence-based integration of TCIM in national health policies and systems based on highest quality research.

This side event, a first step in advancing toward the evidence-related proposals of the Gujarat Declaration, seeks to assess the advances and challenges of integrating TCIM in EIDM institutionalization globally and the needed conditions to strengthen it.

Further information about the side event on the PMAC website:

https://pmac2024.com/activity/73/sidemeetingOnsite/detail

Welcoming and introduction: Tanja Kuchenmller, Unit Head, Evidence to Policy and Impact Unit, Research for Health Department, Science Division, WHO.

Session A. Overview of WHO-led EIDM initiatives, and country-level examples.

Session Chair:Laurenz Mahlanza-Langer, Executive Director, Pan-African Collective for Evidence (PACE), South Africa.

Session B. Global situation assessment / Critical analysis of TCIM-related knowledge translation and TCIM incorporation in EDIM processes.

Session Chair:Amie Steel, Associate Professor, Australian Research Consortium in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Australia.

Session C. Participatory Workshop proposing next steps to address known research and practice gaps for TCIMs inclusion in EIDM

Workshop Co-Facilitators:Mukdarut Bangpan, Associate Professor in Evidence-Informed Policy and Development, University College London, United Kingdom. Amie Steel, Associate Professor, Australian Research Consortium in Complementary and Integrative Medicine, Faculty of Health, University of Technology Sydney, Australia. Daniel F. Gallego-Perez, Postdoctoral Research Fellow, University of North Carolina at Chapel Hill, USA.

Go here to see the original:
Integration of Traditional, Complementary, and Integrative Medicine ...

Worldwide, traditional medicine is used by billions of people for their health and well-being. At a signing ceremony in Geneva, the Government of China committed US$ 5 million over 5 years (20242028) to support the World Health Organization's (WHO) Traditional, Complementary, and Integrative Medicine (TCIM) programme. This financial commitment will also play an important role in advancing the WHO Traditional Medicine Strategy 20252034, which is anticipated to launch at the Seventy-eighth World Health Assembly in May 2025.

Chinas support for traditional medicine has been expressed through a variety of longstanding partnerships with WHO, including the Project Collaboration Agreement signed in 2013 and the memorandum of understanding (MoU) signed in 2018. The signing of the new MoU continues the successful collaboration between WHO and National Administration of Traditional Chinese Medicine (NATCM) in the Government of China and will further enhance research capacity, establish norms and standards for safety and quality, promote appropriate regulation for TCIM, explore the integration of TCIM into health systems, and foster international cooperation in the field of traditional medicine.

"Chinas leadership and commitment to advancing scientific understanding of the safety and effectiveness of Chinese traditional medicine, as well as improving the accessibility and quality of these services within its national health system, are commendable, said Dr Bruce Aylward, Assistant Director-General of the Universal Health Coverage and Life Course division at WHO. "When effectively integrated within national health systems and adapted to local contexts, traditional medicine can play a significant role in achieving universal health coverage, he added.

Professor Yu Yanhong, Commissioner of the National Administration of Traditional Chinese Medicine (NATCM) of China, remarked, NATCM solemnly promises to continue intensifying efforts to share experiences in the field of traditional medicine with a view to address global health challenges, enhance self-management capabilities, and contribute positively to building a health and well-being of individual and society.

Ms Li Weiwei, Minister Counselor of the Permanent Mission of the People's Republic of China to the United Nations Office at Geneva and other International Organizations in Switzerland, added, China remains committed to supporting WHOs efforts to strengthen traditional medicine systems globally. The Permanent Mission of China will continue to foster collaboration between WHO and NATCM, playing an active role in promoting this partnership.

WHOs Traditional, Complementary and Integrative Medicine (TCI) unit is focusing on setting global strategic directions through the Global Traditional Medicine Strategy, monitoring trends in TCI through global surveys, establishing norms and standards through training and practice benchmarks, and advancing terminology standardization. The unit is developing evidence-based technical products to support the safe and effective integration of traditional medicine in national health systems through various activities and programmes.

WHO will continue to work to ensure that traditional medicine is recognized and integrated into health systems globally through the work of the TCI unit and the WHO Global Traditional Medicines Centre (GTMC). The GTMC promotes knowledge-sharing and innovation to harness the potential of traditional medicine for help improve health for all.

Read the rest here:
China and WHO deepen strategic partnership to lead global traditional ...

If You Do This To Fall Asleep, You May Be At Greater Risk Of Dementia  mindbodygreen

Link:
If You Do This To Fall Asleep, You May Be At Greater Risk Of Dementia - mindbodygreen

East Texans enjoy yoga, lectures and food at Integrative Health Matters grand-opening celebration  Tyler Morning Telegraph

See the original post:
East Texans enjoy yoga, lectures and food at Integrative Health Matters grand-opening celebration - Tyler Morning Telegraph

Can Tech Actually Enhance Alternative Medicine? Heres How Its Already Happening  The Boca Raton Tribune

Here is the original post:
Can Tech Actually Enhance Alternative Medicine? Heres How Its Already Happening - The Boca Raton Tribune

Andrew Weil, M.D., is the worlds leading proponent of alternative medicine, right? Wrong.

Although this is how the popular media often portrays him, Dr. Andrew Weil is actually the worlds leading proponent of integrative medicine, a philosophy that is considerably different from a blanket endorsement of alternative medicine. To fully understand Dr. Weils advice presented in his website, bestselling books and lectures, and reflected in the daily practice of thousands of physicians worldwide (thanks to the in-depth training acquired at the Andrew Weil Center For Integrative Medicine at the University Of Arizona in Tucson) its important to grasp what integrative medicine is, and is not.

The first step is mastering some basic terms. Using synthetic drugs and surgery to treat health conditions was known just a few decades ago as, simply, medicine. Today, this system is increasingly being termed conventional medicine. This is the kind of medicine most Americans still encounter in hospitals and clinics. Often both expensive and invasive, it is also very good at some things; for example, handling emergency conditions such as massive injury or a life-threatening stroke. Dr. Weil is unstinting in his appreciation for conventional medicines strengths. If I were hit by a bus, he says, Id want to be taken immediately to a high-tech emergency room. Some conventional medicine is scientifically validated, some is not.

Any therapy that is typically excluded by conventional medicine, and that patients use instead of conventional medicine, is known as alternative medicine. Its a catch-all term that includes hundreds of old and new practices ranging from acupuncture to homeopathy to iridology. Generally alternative therapies are closer to nature, cheaper and less invasive than conventional therapies, although there are exceptions. Some alternative therapies are scientifically validated, some are not. An alternative medicine practice that is used in conjunction with a conventional one is known as a complementary medicine. Example: using ginger syrup to prevent nausea during chemotherapy. Together, complementary and alternative medicines are often referred to by the acronym CAM.

Enter integrative medicine. As defined by the National Center for Complementary and Alternative Medicine at the National Institutes of Health, integrative medicine combines mainstream medical therapies and CAM therapies for which there is some high-quality scientific evidence of safety and effectiveness.

In other words, integrative medicine cherry picks the very best, scientifically validated therapies from both conventional and CAM systems. In his New York Times review of Dr. Weils latest book, Healthy Aging: A Lifelong Guide to Your Physical and Spiritual Well-Being, Abraham Verghese, M.D., summed up this orientation well, stating that Dr. Weil, doesnt seem wedded to a particular dogma, Western or Eastern, only to the get-the-patient-better philosophy.

So this is a basic definition of integrative medicine. What follows is the complete one, which serves to guide both Dr. Weils work and that of integrative medicine physicians and teachers around the world:

Integrative medicine is healing-oriented medicine that takes account of the whole person (body, mind, and spirit), including all aspects of lifestyle. It emphasizes the therapeutic relationship and makes use of all appropriate therapies, both conventional and alternative.

The principles of integrative medicine:

Go here to see the original:
What is Integrative Medicine? - Andrew Weil, M.D. - DrWeil.com

He received his medical degree from Mercer University in Macon, Georgia in 1986 and attended the Pediatric Residency Program at NC Baptist Hospital in Winston-Salem, North Carolina with an emphasis in Preventive Medicine. Later, while serving as Emergency Department Director at hospitals in Rocky Mount and Southport, NC, he began exploring ways to combine conventional medicine with nutrition, botanicals, and other natural therapies as an integral part of clinical medical practice.

Since founding the Carolina Center in 1994, Dr. Pittman has further enhanced his understanding of integrative medicine through clinical training at the Autism Research Institute and the International Lyme and Associated Diseases Societys Physician Training Program.

He has lectured frequently at the UNC School of Medicines Program on Integrative Medicine and presently serves as a member of the states Vector Disease Task Force and was the former President of the North Carolina Integrative Medicine Society. From the beginning, Dr. Pittmans vision for the Center was to bring together multiple healing modalities in order to help patients overcome chronic degenerative illnesses and bolster their health and wellness.

Visit link:
Integrative Doctor | The Carolina Center for Integrative Medicine

Spotlight on Wellness: the revolutionary world of integrative and regenerative medicine  Daily Tribune (Philippines)

Follow this link:
Spotlight on Wellness: the revolutionary world of integrative and regenerative medicine - Daily Tribune (Philippines)

SAN DIEGO, July 11, 2024 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”), a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel classes of therapeutic drugs that modulate the endocannabinoid system, today announced that it will host a virtual KOL event entitled “Metabolic Rewiring with CB1 Inhibition” on Wednesday, July 24, 2024, at 9:00 AM ET.

Excerpt from:
Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th

ALPHARETTA, Ga., July 11, 2024 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (Nasdaq: CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space (SCS®), announced today the appointment of Glenn C. Yiu, M.D., Ph.D., Professor of Ophthalmology at the University of California, Davis, to its Scientific Advisory Board (SAB), which is comprised of industry-leading retinal physicians who provide medical and scientific expertise and input on the Company’s research and development programs.

Here is the original post:
Clearside Biomedical Appoints Dr. Glenn Yiu to its Scientific Advisory Board

NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline

View post:
NMD Pharma adds new capabilities with several senior recruits to support its growing business and pipeline

This marks the first export into Asia, the 18th international market for Aureus branded products and 21st market for all Avicanna products

See original here:
Avicanna Subsidiary Completes Export of Aureus Branded CBG into Singapore

LAUPHEIM, Germany and MILFORD, Mass., July 11, 2024 (GLOBE NEWSWIRE) -- Rentschler Biopharma SE, a leading global contract development and manufacturing organization (CDMO) for biopharmaceuticals, including advanced therapy medicinal products (ATMPs), today announced that the company’s new state-of-the-art production line, formerly known as the Rentschler Biopharma Manufacturing Center (RBMC), in Milford, MA in the U.S. is now fully operational. The company has a major project underway at the new line, with several additional projects in the pipeline, and continues to welcome new projects and clients.

Continued here:
Rentschler Biopharma Announces New State-of-the-Art Production Line in Massachusetts is Fully Operational

CLEVELAND and LONDON, July 11, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a cell and gene therapy company with proprietary adeno-associated virus (AAV)-based capsids, and Beacon Therapeutics, an ophthalmic gene therapy company and Syncona portfolio company, today announced an agreement by which Beacon will evaluate Abeona's patented AAV204 capsid for the development and commercialization of potential gene therapies for select ophthalmology indications.

Go here to read the rest:
Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204...